A skilled nursing facility may accept a resident with hemophilia while leaving the most expensive question unresolved: who obtains the prescribed clotting factor, administers it and bills for it. Settle those points before accepting a bed. A clinical “yes” without a named supplier and written medication plan can unravel on transfer day.
CMS states that certain blood clotting factors and related furnishing services are excluded from SNF consolidated billing. Its 2026 explanation places them among services that may be billed separately during a covered Part A stay. That does not make every product or claim covered or cost-free. The exact product, code, Part B status and supplier still need verification.
Start with the current hemophilia treatment plan
Ask the hospital and hemophilia treatment center for one reconciled plan. It should identify the diagnosis, factor deficiency, inhibitor status, prescribed product, dose, route, prophylaxis schedule, last administration and instructions for suspected bleeding. Do not let a facility substitute a generic phrase such as “factor VIII as needed” for the actual order.
Include allergies, venous-access information, recent laboratory results and the specialist’s contact route. If the patient uses a newer or extended-half-life product, record the precise brand and units. Products are not interchangeable merely because they treat the same factor deficiency. The accepting clinician must confirm the order and what monitoring is required.
Identify who will obtain the factor
Before choosing the room, name the dispensing or furnishing entity. It may be a specialty pharmacy, the treatment center’s pharmacy program or another Medicare-enrolled supplier. Ask whether it can deliver to the SNF, which payer information it needs, how much lead time is required and what happens if admission occurs before the next scheduled shipment.
The facility should state whether it will receive resident-specific stock, where it will keep it and how staff will verify lot number and expiration. Never assume the hospital will send an indefinite supply. A transfer quantity is a bridge, not a procurement plan, unless the discharge paperwork says otherwise.
Confirm who can administer each dose
Some people with hemophilia self-infuse after training; others need a nurse or treatment-center visit. An FDA-approved product’s instructions may expressly say that self-administration should occur only after appropriate training. The SNF must decide what it can safely support for this individual rather than relying on family habit.
Ask who will reconstitute and administer scheduled or emergency doses on every relevant shift, how competency is documented, and whether outside nursing is involved. If the resident self-infuses, obtain a written assessment of capacity, storage access, supervision and documentation. A relative should not become the unspoken backup required to make the admission workable.
Read the Medicare billing exclusion correctly
For a resident whose SNF stay is covered by Part A, the facility submits most Medicare service claims under consolidated billing. CMS identifies certain clotting factors and related furnishing services as excluded items. The exclusion allows separate billing when the service and claim meet the applicable rules; it is not a blanket promise of payment.
Ask the supplier for the product’s HCPCS code, the expected claim route, assignment status and any prior documentation requirement. Confirm that the resident has Part B eligibility and ask for an estimate of deductible or coinsurance exposure. The SNF and supplier should agree in writing about who bills for the drug, administration supplies and professional service so the same item is not charged twice.
Separate the covered SNF stay from long-term residence
A short Medicare-covered rehabilitation stay and a permanent nursing-home placement are different payment situations. CMS explains that consolidated billing mainly applies while Part A covers the SNF stay; most services during a noncovered residence follow other billing arrangements, apart from specified therapy rules. Medicaid, a Medicare Advantage plan, employer coverage or private payment may change the path again.
Build two budgets if long-term placement is possible. The first should cover the Part A period and expected cost sharing. The second should show the room rate, payer transition, factor coverage and resident liability after Part A ends. Do not accept a quote that simply says “Medicare covers the medication” without identifying which Medicare part, claim and time period.
Verify storage product by product
Clotting-factor storage rules differ. Use the current FDA-approved labeling for the exact product and ask the supplier to provide handling instructions with each shipment. Record permitted temperature range, whether room-temperature storage is allowed, whether the product can return to refrigeration, protection from light, reconstitution deadline and what counts as an excursion.
Inspect the proposed storage location. It should protect resident-specific medication, allow documented temperature control where required and remain accessible to authorized staff when a dose is due. Ask who responds to a refrigerator failure, delivery delay or damaged package and who contacts the pharmacy for replacement.
Build a bleeding-response plan before transfer
The written plan should distinguish routine prophylaxis from a suspected bleed or injury. It needs observable warning signs, whom staff call first, when factor is given under the order, when emergency services are used and which hospital or hemophilia treatment center receives the resident. The CDC describes federally supported hemophilia treatment centers as specialized sources of comprehensive bleeding-disorder care; keep that relationship active during the SNF stay.
Ask how falls, head injuries, new pain, swelling or neurologic changes are escalated and documented. Verify night and weekend coverage rather than accepting a weekday-only answer. If transfer is required, specify what medication, order, treatment record and specialist information travel with the resident.
Request a complete written cost map
The quote should separate room and board, skilled nursing, therapy, ordinary medications, clotting factor, supplies, administration, laboratory work, specialist visits and transportation. For each line, identify the expected payer, billing entity, authorization status and estimated resident responsibility. Mark unknown amounts rather than hiding them inside “included.”
Ask about deposits, advance payment and any separate pharmacy agreement. Review refunds if the bed, clinical acceptance or delivery fails. Federal rules prohibit certified nursing facilities from requiring a third-party payment guarantee or gift as an admission condition; a representative may agree to use the resident’s funds without assuming personal liability.
Test the admission decision against actual capability
Send the same clinical packet to each candidate and require a dated answer. The admissions team should confirm an available bed, the level of care, factor workflow, staffing, pharmacy coordination, emergency response and any reason the facility believes it cannot meet the need. A place on a referral list is not a reserved bed.
Federal rules require certified facilities to maintain admission policies and equal access to quality care regardless of diagnosis or payment source. They do not force acceptance when needs cannot be met. Ask, “Can you execute this named plan on the required date?”
Compare facilities with an evidence matrix
Use one row per facility and columns for confirmed bed date, Medicare certification, treatment-plan acceptance, named factor supplier, delivery lead time, trained administrator, after-hours coverage, storage, emergency destination, billing route and total initial cash requirement. Add Care Compare ratings, inspection findings and staffing information, but do not let a star rating replace the medication-specific checks.
Score unresolved items as risks. A lower room quote may cost more if the family must arrange transport or face an unclear specialty-pharmacy bill. Prefer answers from a pharmacist, nursing director or billing specialist.
Control referral fees and conflicts
Before using a placement company, ask whether the family, the facility or both pay it. Request the compensation trigger, participating-provider limits and any preferred-placement arrangement in writing. A recommendation should remain explainable when a suitable SNF pays no referral commission.
Curalune’s option-selection service can organize candidates around the prescribed factor plan, timing and cost constraints. With the fuller contact service, selected facilities receive a consistent question set covering the bed, supplier, administration, billing and contract, giving the family comparable answers. Neither an available bed nor admission is guaranteed by Curalune, and it cannot promise Medicare payment, drug supply, clinical acceptance or the final cost.
Questions to resolve before saying yes
Does the consolidated-billing exclusion mean the factor is free?
No. It permits qualifying services to be billed separately. Coverage, coding, supplier enrollment and cost sharing still must be checked.
Can the family bring factor from home?
Only under an approved facility and pharmacy process. The SNF should verify prescription, custody, storage, lot and expiration and record each dose.
Can a resident continue self-infusion in the SNF?
Possibly, but not automatically. The resident needs appropriate training and an individualized facility assessment addressing capacity, storage, technique, supervision and documentation.
What if the supplier cannot deliver by admission day?
Do not rely on a verbal promise. Ask the hospital, treatment center, supplier and SNF to document a safe bridge or change the transfer date. Curalune cannot guarantee that a shipment or bed will remain available.
Should a relative sign a personal payment guarantee?
Do not assume personal liability is necessary. Certified nursing facilities cannot require a third-party guarantee as an admission condition. Have any disputed clause reviewed before signing and distinguish use of the resident’s funds from a relative’s own guarantee.